Which of the following vasopressors woul be preferred in a patient with aortic stenosis
**Core Concept**
Aortic stenosis is a condition characterized by the narrowing of the aortic valve opening, leading to impaired blood flow from the left ventricle to the aorta. In patients with aortic stenosis, the preferred vasopressor should have minimal impact on the already compromised left ventricular function.
**Why the Correct Answer is Right**
In patients with aortic stenosis, norepinephrine is the preferred vasopressor. This is because norepinephrine primarily acts on alpha-1 receptors, causing vasoconstriction and increasing blood pressure. Unlike other vasopressors like epinephrine or phenylephrine, norepinephrine has minimal impact on the heart rate and contractility, making it a safer choice for patients with aortic stenosis. Additionally, norepinephrine's effect on beta-1 receptors is minimal, which reduces the risk of exacerbating left ventricular dysfunction.
**Why Each Wrong Option is Incorrect**
**Option A:** Epinephrine is not preferred in aortic stenosis because it has a significant effect on beta-1 receptors, increasing heart rate and contractility, which can worsen left ventricular function.
**Option B:** Phenylephrine is not ideal because it primarily acts on alpha-1 receptors, causing vasoconstriction, but it also has a significant impact on venous return, which can decrease cardiac output in patients with aortic stenosis.
**Option D:** Vasopressin is not the preferred choice because it has a variable effect on blood pressure and can cause pulmonary hypertension, which may be detrimental in patients with aortic stenosis.
**Clinical Pearl / High-Yield Fact**
When managing patients with aortic stenosis, it's essential to use vasopressors judiciously and consider the potential impact on left ventricular function. Norepinephrine's minimal effect on beta-1 receptors makes it a safer choice, but close monitoring of cardiac function is still necessary.
**Correct Answer:** C.